Ocean Biomedical enters first in-human clinical trial

Ocean Biomedical and Virion Therapeutics form JV for chronic hepatitis study

Ocean Biomedical forms JV with Virion Therapeutics to find treatments for cancer and chronic infectious diseases

Ocean Biomedical and Virion Therapeutics form JV for chronic hepatitis study

Ocean Biomedical Announces Newly Published Findings Demonstrating Ability to Restore Treatment Sensitivity to AstraZeneca’s Leading Lung Cancer Drug After Resistance Has Formed, and Enhanced Tumor Suppression in EGFR-Mutation Lung Cancers

Ocean Biomedical’s cancer-targeting antibody candidate shows effective tumor reduction against a subset of NSCLC with EGFR mutations

Ocean Biomedical (NASDAQ: OCEA) Announces New Patent for Anti-Fibrosis Discovery with Allowance in Alcoholic Liver Disease and Multiple Fibrotic Conditions, Leading Causes of Death in the U.S.

Ocean Biomedical Announces New Patent For Fibrosis Candidate Catering To One Of Leading Death Causes In US

Ocean Biomedical: Some New Targets, No Clinical Data. Not For Me